Cornerstone Planning Group’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.7K Sell
52
-18
-26% -$4.73K ﹤0.01% 773
2026
Q1
$17.8K Buy
70
+10
+17% +$2.71K ﹤0.01% 711
2025
Q4
$16.1K Sell
60
-1
-2% -$266 ﹤0.01% 643
2025
Q3
$15.4K Hold
61
– – ﹤0.01% 655
2025
Q2
$16.1K Sell
61
-14
-19% -$3.41K ﹤0.01% 461
2025
Q1
$16.8K Buy
75
+39
+108% +$9.46K ﹤0.01% 448
2024
Q4
$8.99K Buy
36
+4
+13% +$918 ﹤0.01% 449
2024
Q3
$7.3K Sell
32
-9
-22% -$1.98K ﹤0.01% 485
2024
Q2
$9.37K Sell
41
-8
-16% -$1.63K ﹤0.01% 455
2024
Q1
$9.87K Hold
49
– – ﹤0.01% 410
2023
Q4
$11.1K Sell
49
-1
-2% -$210 ﹤0.01% 411
2023
Q3
$10.1K Buy
50
+15
+43% +$3.16K ﹤0.01% 420
2023
Q2
$7.24K Buy
+35
New +$6.79K ﹤0.01% 773
2022
Q4
$4.55K Buy
+21
New +$4.1K ﹤0.01% 939

Other funds holding LH

Cornerstone Planning Group's LH Position: Q2 2026 in Review

Cornerstone Planning Group reduced its Labcorp (LH) stake by 26% in Q2 2026, selling an estimated $4.73K and leaving 52 shares worth $14.7K. The position accounts for ﹤0.01% of the portfolio, ranked #773.

Cornerstone Planning Group first reported a position in LH in Q4 2022 and has held it in 14 quarters since. The position peaked at $17.8K in Q1 2026. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Cornerstone Planning Group held 52 shares of Labcorp worth $14.7K as of Q2 2026.
  • Cornerstone Planning Group sold 18 Labcorp shares in Q2 2026, an estimated $4.73K.
  • Labcorp made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q2 2026, its #773 holding.
  • Cornerstone Planning Group first reported a position in Labcorp in Q4 2022 and has held it in 14 quarters since.
  • Cornerstone Planning Group's Labcorp position peaked at $17.8K in Q1 2026.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.